NGNE: Neurogene Company Short-Term Debt

NGNE (Neurogene Corp) - company brandmark

This price chart on GURU.Markets illustrates the price action of Neurogene Inc. (NGNE), where the specific short-term debt metric stands at 0.01. This biotech player focuses on developing gene therapies for children with rare brain pathologies, planning future profits from the implementation of new drugs. Meanwhile, the business operates within a stable US legal climate, remaining shielded from global trade conflicts due to the humanitarian status of medicine.

NGNE neurogene.com Company Short-Term Indebtedness (02/21/2024 - 10/30/2026)

Summary analytical data breakdowns for Neurogene Therapeutics (NGNE)

- current quotes and average value forecast:
Price Chart Neurogene|NGNE - Fair Value Consensus
- market capitalization information:
Market Value Neurogene Inc.|NGNE - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Neurogene|NGNE - Accounting Capitalization|Market Capitalization to Book Value Ratio neurogene.com|NGNE - Company Assets
- debt and liquidity details:
Total Debt to Equity Ratio Neurogene Inc.|NGNE - Long-Term Debt to Capital|Short-Term Debt to Equity Neurogene Inc.|NGNE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Neurogene Inc.|NGNE - Long-Term Debt|Company Short-Term Debts Neurogene|Quick Ratio neurogene.com
- earnings and multiples data:
NGNE - Company Net Income
General company analysis:NGNE - Neurogene
Flagship merchandise of Neurogene Inc.

This metric aggregates all obligations of Neurogene Inc. (NGNE) due for repayment within twelve months. This metric determines the company's ability to service loans without compromising operational activities. For a biopharmaceutical startup, such loans often fund the costly development of viral vectors. Liquidity assessment is critical given high R&D expenditures. By analyzing the short-term debt trend, an investor evaluates the financial stability of the gene therapy business.

Main competitors

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|Company Short-Term Indebtedness XENE (xenon-pharma.com)|Company Short-Term Debts VKTX|SUPN - Short-Term Debt|Catalyst Pharmaceuticals Inc - Company Current Liabilities|Company Short-Term Debts Denali Corp DNLI|HRMY - Company Short-Term Debt|Company Short-Term Loans and Borrowings BHVN (biohavenpharma.com)|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Short-Term Debt Trevi Therapeutics Inc (TRVI)|PRAX (Praxis Medicines) - Company Short-Term Debts|AVXL - Short-Term Indebtedness|Company Short-Term Debts CBLL|PRTA - Short-Term Debt|Company Short-Term Debt Alector ALEC|ANNX: Company Short-Term Indebtedness|Omeros Corp. - Company Short-Term Debts|Short-Term Debt AC Immune Inc|VYGR (Voyager Therapeutics) - Company Current Liabilities|neumoratx.com - Company Short-Term Loans and Borrowings|SCLX (Scilex) - Company Short-Term Debts|Tevogen Bio Holdings Inc. (TVGN) - Short-Term Debt Volume|Company Short-Term Debt Alpha Cognition (ACOG)|cogrx.com - Company Short-Term Indebtedness|Company Short-Term Debts IKT (Inhibikase Therapeutics)|SAVA - Company Current Liabilities|ASRT: Company Current Liabilities|Short-Term Debt Volume Coya Therapeutics, Inc. COYA|vistagen.com (VTGN) - Company Short-Term Debt|Company Short-Term Indebtedness OVID|ABOS (Acumen Pharmaceuticals) - Company Short-Term Debts|CRVO - Short-Term Indebtedness|Company Short-Term Debt Alterity Therapeutics (ATHE)|clene.com - Company Short-Term Indebtedness|Company Short-Term Debts PEPG (PepGen)|jupiterneurosciences.com (JUNS) - Short-Term Debt|RLMD - Company Short-Term Debt|ANVS (annovisbio.com) - Company Short-Term Indebtedness|GRCE: Company Short-Term Debts|Short-Term Debt Firefly Neuroscience, Inc. (AIFF)|Company Current Liabilities KLTO|Company Short-Term Debts NeuroSense Therapeutics, Ltd.|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|MTVA (metaviatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NeurAxis NRXS|Helius Medical Technologies, Inc. (HSDT) - Short-Term Debt|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Current Liabilities ADXN|Company Short-Term Debts Alzamend|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Short-Term Debt|Avenue Therapeutics, Inc. - Company Short-Term Debts|Short-Term Indebtedness Brainstorm Cell Therapeutics Inc. (BCLI)|CARA: Company Short-Term Debts|Short-Term Debt Chromocell (CHRO)|Company Short-Term Debt Eliem Therapeutics, Inc.|Company Short-Term Indebtedness ITCI (Intra-Cellular)|Company Short-Term Debts LBPH|MRNS - Short-Term Debt|NKGen - Company Current Liabilities|Company Short-Term Loans and Borrowings NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume synaptogen.com SNPX|Trevena (TRVN) - Company Short-Term Debt|Company Short-Term Indebtedness VIGL|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Company Current Liabilities Cerevel Corp (CERE)